Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock

A López, JA Lorente, J Steingrub, J Bakker… - Critical care …, 2004 - journals.lww.com
Multiple-center, randomized, placebo-controlled, double-blin... : Critical Care Medicine
Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase
inhibitor 546C88: Effect on survival in patients with septic shock* : Critical Care Medicine
SCCM Pediatric Critical Care Medicine Critical Care Explorations Log in or Register Subscribe
to journalSubscribe Get new issue alertsGet alerts Secondary Logo Journal Logo Advanced
Search Toggle navigation Subscribe Register Login Articles & Issues Latest Articles Collections …